is a prescription medication that acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. Scientists at 3M s pharmaceuticals division discovered the drug and 3M obtained the first FDA approval in 1997 under the brand Aldara . is a topical medication that activates the immune system and is used for treating genital warts.Although the exact mechanism of action is not known, is presumed to work by activating immune cells and chemicals that affect the immune the system. Find patient medical information for Imiquimod Topical on including its uses, side effects and safety, interactions, pictures, warnings and user ratings. The global cosmetic outcomes in the study comparing topical , topical 5-FU, and cryotherapy were not significantly different after completion of . 25 However, after 12 months of follow-up, investigator assessments rated the cosmetic outcome as excellent in 81 percent of topical -treated subjects, as compared to four is approved to treat: Basal cell carcinoma that is superficial. Actinic keratosis. Genital warts. is also being studied in the treatment of other conditions and types of cancer. More About . Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. cream is used to treat certain types of actinic keratoses on the face or scalp. cream is also used to treat superficial basal cell carcinoma on the imiquimod trunk, neck, arms, hands, legs, or feet is a synthetic imidazoquinolone amine, which has potent immune response modifier activity, when topically used. This characteristic property of has led to its use in a number of applications in dermatology, particularly in cutaneous malignancies, where it has been found to be Cream should be applied prior to normal sleeping hours and left on the Imiquimod skin for approximately 8 hours, then removed by washing the area with mild soap and water. The prescriber should demonstrate the proper application technique to maximize the benefit of Cream . 3.75% cream has recently been approved by both the FDA and Health Canada for the treatment of external genital warts. This article is an overview of EGW, phase 3 clinical trials leading to the approval of 3.75% cream, and comparison with 5% cream. What is imiquimod? Imiquimod is a an immune response modifier. It is manufactured as a 5% cream called Aldara™. Generic forms of imiquimod cream are also available. The Perrigo brand is funded by PHARMAC in New Zealand . The evidence supporting this license comes from three prospective, double-blind, randomized, vehicle-controlled trials.22–,24 In these trials 698 immunocompetent individuals were randomized to receive topical with 5% cream, 1% cream or best place to buy cialis online
vehicle control. Treatment usually is surgical, but nonsurgical modalities such as combination with and 5-aminolevulinic acid–based photodynamic should be considered in patients who are poor surgical candidates or in cases of recurrences after excisional surgery. CDC and others recommend that external HPV warts be treated with a self-administered topical , a topical administered by a health-care provider , or a surgical technique . 2 3 5 6 15 20 No patients progressed to invasive cancer while receiving . Conclusion: Topical 5% cream is a safe and feasible option for women suffering from recurrent extramammary Pagets is a prescription medicine that you use at home. It comes in a cream that you apply to your skin. Your dermatologist may prescribe to treat: Actinic keratosis . Basal cell carcinoma . Genital warts. Sometimes, a Background: Tissue-destructive and more selective cytotoxic therapies are the main methods used to treat actinic cheilitis. A topical immune stimulant, 5% cream, has recently been used for treatment of cutaneous epithelial malignancies including squamous cell carcinoma in situ and basal cell carcinoma. can either be used alone or in combination with other treatment modalities. The most common adverse effects of topical use of are localized to the site of application and easily managed. Key Words: , , , skin has some theoretical advantages over other therapies in that it is easy to apply, well-tolerated and cosmetically acceptable, may also clear distant lesions. However, the cost of is a disadvantage. Conclusions. Imiquimod Topical appears to be a useful agent for non-genital cutaneous warts, with reasonable efficacy and good Giving vaccine together with may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine and to see how well it works when given with or Imiquimod with . Biological therapies, such as , may stimulate the immune system in different ways and stop cancer cells from growing. Giving vaccine together with may be a better treatment for cervical intraepithelial neoplasia.